Biblio

Found 312 results
2017
Yeh C-Y, Bulas AM, Moutal A, Saloman JL, Hartnett KA, Anderson CT, Tzounopoulos T, Sun D, Khanna R, Aizenman E.  2017.  Targeting a Potassium Channel/Syntaxin Interaction Ameliorates Cell Death in Ischemic Stroke.. J Neurosci. 37(23):5648-5658.
Grenald SA, Doyle TM, Zhang H, Slosky LM, Chen Z, Largent-Milnes TM, Spiegel S, Vanderah TW, Salvemini D.  2017.  Targeting the S1P/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation.. Pain. 158(9):1733-1742.
Varadaraj A, Jenkins LM, Singh P, Chanda A, Snider J, Lee NY, Amsalem-Zafran AR, Ehrlich M, Henis YI, Mythreye K.  2017.  TGF-β triggers rapid fibrillogenesis via a novel TβRII-dependent fibronectin-trafficking mechanism.. Mol Biol Cell. 28(9):1195-1207.
2016
Zhang Y, Williams DA, Zaidi SA, Yuan Y, Braithwaite A, Bilsky EJ, Dewey WL, Akbarali HI, Streicher JM, Selley DE.  2016.  17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-(4'-pyridylcarboxamido)morphinan (NAP) Modulating the Mu Opioid Receptor in a Biased Fashion.. ACS Chem Neurosci. 7(3):297-304.
Zhang L, Trushin S, Christensen TA, Bachmeier BV, Gateno B, Schroeder A, Yao J, Itoh K, Sesaki H, Poon WW et al..  2016.  Altered brain energetics induces mitochondrial fission arrest in Alzheimer's Disease.. Sci Rep. 6:18725.
Jenkins LM, Singh P, Varadaraj A, Lee NY, Shah S, Flores HV, O'Connell K, Mythreye K.  2016.  Altering the Proteoglycan State of Transforming Growth Factor β Type III Receptor (TβRIII)/Betaglycan Modulates Canonical Wnt/β-Catenin Signaling.. J Biol Chem. 291(49):25716-25728.
Forte BL, Slosky LM, Zhang H, Arnold MR, Staatz WD, Hay M, Largent-Milnes TM, Vanderah TW.  2016.  Angiotensin-(1-7)/Mas receptor as an antinociceptive agent in cancer-induced bone pain.. Pain. 157(12):2709-2721.
Cowell SM, Lee YSun.  2016.  Biphalin: The Foundation of Bivalent Ligands.. Curr Med Chem. 23(29):3267-3284.
Espeland MA, Erickson K, Neiberg RH, Jakicic JM, Wadden TA, Wing RR, Desiderio L, Erus G, Hsieh M-K, Davatzikos C et al..  2016.  Brain and White Matter Hyperintensity Volumes After 10 Years of Random Assignment to Lifestyle Intervention.. Diabetes Care. 39(5):764-71.
Lee YSun, Remesic M, Ramos-Colon C, Hall SM, Kuzmin A, Rankin D, Porreca F, Lai J, Hruby VJ.  2016.  Cyclic non-opioid dynorphin A analogues for the bradykinin receptors.. Bioorg Med Chem Lett. 26(22):5513-5516.
Remesic M, Lee YSun, Hruby VJ.  2016.  Cyclic Opioid Peptides.. Curr Med Chem. 23(13):1288-303.
Slosky LM, BassiriRad NM, Symons AM, Thompson M, Doyle T, Forte BL, Staatz WD, Bui L, Neumann WL, Mantyh PW et al..  2016.  The cystine/glutamate antiporter system xc- drives breast tumor cell glutamate release and cancer-induced bone pain.. Pain. 157(11):2605-2616.
Hall SM, LeBaron L, Ramos-Colon C, Qu C, Xie JYanhua, Porreca F, Lai J, Lee YSun, Hruby VJ.  2016.  Discovery of Stable Non-opioid Dynorphin A Analogues Interacting at the Bradykinin Receptors for the Treatment of Neuropathic Pain.. ACS Chem Neurosci. 7(12):1746-1752.
Hall SM, Lee YSun, Hruby VJ.  2016.  Dynorphin A analogs for the treatment of chronic neuropathic pain.. Future Med Chem. 8(2):165-77.
Karim R, Dang H, Henderson VW, Hodis HN, St John J, Brinton RD, Mack WJ.  2016.  Effect of Reproductive History and Exogenous Hormone Use on Cognitive Function in Mid- and Late Life.. J Am Geriatr Soc. 64(12):2448-2456.
Deekonda S, Cole J, Sunna S, Rankin D, Largent-Milnes TM, Davis P, BassiriRad NM, Lai J, Vanderah TW, Porecca F et al..  2016.  Enkephalin analogues with N-phenyl-N-(piperidin-2-ylmethyl)propionamide derivatives: Synthesis and biological evaluations.. Bioorg Med Chem Lett. 26(1):222-7.
Islam MRashedul, Yang L, Lee YSun, Hruby VJ, Karamyan VT, Abbruscato TJ.  2016.  Enkephalin-Fentanyl Multifunctional Opioids as Potential Neuroprotectants for Ischemic Stroke Treatment.. Curr Pharm Des. 22(42):6459-6468.
Ronaldson PT, Bauer B, El-Kattan AF, Shen H, Salphati L, Louie SW.  2016.  Highlights From the AM Assoc of Pharmaceutical Scientists/International Transporter Consortium Joint Workshop on Drug Transporters in Absorption, Distribution, Metabolism, and Excretion: From the Bench to the Bedside - Clinical Pharmacology Considerations. Clin Pharmacol Ther. 100(5):419-422.
Rettberg JR, Dang H, Hodis HN, Henderson VW, St John JA, Mack WJ, Brinton RDiaz.  2016.  Identifying postmenopausal women at risk for cognitive decline within a healthy cohort using a panel of clinical metabolic indicators: potential for detecting an at-Alzheimer's risk metabolic phenotype.. Neurobiol Aging. 40:155-63.
Brinton RDiaz.  2016.  Neuroendocrinology: Oestrogen therapy affects brain structure but not function.. Nat Rev Neurol. 12(10):561-2.
Shah N, Lee NY.  2016.  Regulation of gene expression and mitochondrial dynamics by SMAD.. Mol Cell Oncol. 3(5):e1204492.
Kumar NN, Gautam M, Lochhead JJ, Wolak DJ, Ithapu V, Singh V, Thorne RG.  2016.  Relative vascular permeability and vascularity across different regions of the rat nasal mucosa: implications for nasal physiology and drug delivery.. Sci Rep. 6:31732.
Moutal A, Dustrude ET, Khanna R.  2016.  Sensitization of Ion Channels Contributes to Central and Peripheral Dysfunction in Neurofibromatosis Type 1.. Mol Neurobiol.
Snyder HM, Asthana S, Bain L, Brinton R, Craft S, Dubal DB, Espeland MA, Gatz M, Mielke MM, Raber J et al..  2016.  Sex biology contributions to vulnerability to Alzheimer's disease: A think tank convened by the Women's Alzheimer's Research Initiative.. Alzheimers Dement. 12(11):1186-1196.
Zhao L, Mao Z, Woody SK, Brinton RD.  2016.  Sex differences in metabolic aging of the brain: insights into female susceptibility to Alzheimer's disease.. Neurobiol Aging. 42:69-79.

Pages